This is not about low quality drugs.. if TauRx goes through the rigour and transparency of their clinical trials and subsequent regulatory approval. The point you highlighted above pertains to a different issue: the presence of counterfeit drugs.
Ah.... @Choysun my old friend, we have already seen a few Musang Kings before including cha cha aunty LoserSSP, thereafter the baton was passed to her buddy with a Genting logo, and now another new Musang King who "learns to rock". Usually they will be doing non-stop numerous posts everyday, start attacks / false accusations against others.
To the past, present and future Musang Kings, better dont waste time on such ambitions. Posting on social media forums makes no money and its a distraction to observing real money making opportunities. Stay low profile, watch for opportunities to make money more important.
It’s good to see a non Genting investor recognize that posting on social media doesn’t make money and can be a distraction from real opportunities. Staying low profile and focusing on making money is key. Avoid online bullying..
A genting investor posting non-stop n start attacking others wont make money also la. Im a Genting stock trader, its ok to post here. Which durian Musang King is saying dont post trading stuff here?
We’re pleased to announce the Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed acceptance of the UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM), a 4 mg oral tablet for the treatment of mild cognitive impairment (MCI-AD) and mild to moderate Alzheimer’s disease.
This application is being reviewed within the scope of the 150-day accelerated assessment procedure, which is used by MHRA to accelerate the availability of medicines for patients in the UK.
Posted by Michaelchan2024 > 13 hours ago | Report Abuse ATK, following validation, the MHRA aims to complete the detailed assessment within 150 days. So we should know the outcome by Dec 2024, right? -----------
Hopefully the best Christmas present for all Genting & Taurx shareholders 😀😀
We’re pleased to announce the Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed acceptance of the UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM), a 4 mg oral tablet for the treatment of mild cognitive impairment (MCI-AD) and mild to moderate Alzheimer’s disease.
This application is being reviewed within the scope of the 150-day accelerated assessment procedure, which is used by MHRA to accelerate the availability of medicines for patients in the UK.
We look forward to sharing further updates as the application progresses.
Posted by neohts > 15 minutes ago | Report Abuse why still got so many sellers? -------------
Maybe they didnt know this Christmas Genting might have a big present? Too many traders and investors la, dont bother abt what they do or something you have no control over. Their own money, their own buy/sell decisions. Have your own strategy and stick to your own plan.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Junichiro
2,057 posts
Posted by Junichiro > 2 months ago | Report Abuse
"Pfizer COVID-19 vaccine " high quality ??? I doubt it , looking at its side effects. It needs lots of refinement.